New Delhi, February 24 Dr. Reddy's Laboratories said on Tuesday that the U.S. Securities and Exchange Commission has not recommended any enforcement action against it due to an anonymous complaint alleging improper payments to healthcare professionals in Ukraine and other countries.The...
bse
corporate governance
corporate law
dr. reddy's laboratories
financial compliance
healthcare professionals
improper payments
regulatory investigations
sebi
sec
share prices
u.s. department of justice
u.s. foreign corrupt practices act
u.s. securities and exchange commission
ukraine